Molecular mechanisms of hormone-mediated Mullerian duct regression: involvement of beta-catenin

QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

This Article

	Summary
	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted

Services

	Email this article to a friend
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Download to citation manager


Citing Articles

	Citing Articles via HighWire
	Citing Articles via Google Scholar

Google Scholar

	Articles by Allard, S.
	Articles by Xavier, F.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Allard, S.
	Articles by Xavier, F.

Aberle, H., Schwartz, H. and Kemler, R (1996). Cadherin-catenin complex protein interactions and their implications for cadherin function. J. Cell Biochem 61, 513-523.

Austin, H. B (1995). Dil analysis of cell migration during Mullerian duct regression. Dev. Biol 169, 29-36.[Medline]

Baarends, W. M., van Helmond, M. J., Post, M., van der Schoot, P. J., Hoogerbrugge, J. W., de Winter, J. P., Uilenbrock, J. T., Karels, B., Wilming, L. G., Meijers, J. H. C. et al (1994). A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct. Development 120, 189-197.[Abstract]

Behrens, J. von Kries, J. P., Kuhl, M., Bruhn, L., Wedlich, D. and Grosschedl, R (1996). Functional interaction of-catenin with the transcription factor LEF-1. Nature 382, 638-642.[Medline]

Behringer, R. R., Cate, R. L., Froelick, G. J., Palmiter, R. D. and Brinster, R. L (1990). Abnormal sexual development in transgenic mice chronically expressing Mullerian inhibiting substance. Nature 345, 167-170.[Medline]

Behringer, R. R., Finegold, M. J. and Cate, R. L (1994). Mullerian-inhibiting substance function during mammalian sexual development. Cell 79, 415-425.[Medline]

Blanchard, M. G. and Josso, N (1974). Source of the anti-Mullerian hormone synthesized by the fetal testis: Mullerian-inhibiting activity of fetal bovine Sertoli cells in tissue culture. Pediatr. Res 8, 968-971.

Boudreau, N., Sympson, C. J., Werb, Z. and Bissell, M. J (1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893.[Abstract/Free Full Text]

Carre-Eusebe, D., Imbeaud, S., Harbison, M., New, M. I., Josso, N. and Picard, J. Y (1992). Variants of the anti-Mullerian hormone gene in a compound heterozygote with the persistent Mullerian duct syndrome and his family. Hum. Genet 90, 389-394.[Medline]

Cate, R. L., Mattaliano, R. J., Hession, C., Tizard, R., Farber, N. M., Ninfa, E. G., Frey, A. Z., Gash, D. J., Chow, E. P., Fisher, R. A., et al (1986). Isolation of the bovine and human genes for mullerian inhibiting substance and expression of the human gene in animal cells. Cell 45, 685-698.[Medline]

Catlin, E. A., Tonnu, V. C., Ebb, R. G., Pacheco, B. A., Manganaro, T. F., Ezzell, R. M., Donahoe, P. K. and Teixeira, J (1997). Mullerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung. Endocrinology 138, 790-796.[Abstract/Free Full Text]

di Clemente, N., Wilson, C., Faure, E., Boussin, L., Carmillo, P., Tizard, R., Picard, J. L., Vigier, B., Josso, N. and Cate, R (1994). Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol. Endocrinol 8, 1006-1020.[Abstract]

Dyche, W. J (1979). A comparative study of the differentiation and involution of the Mullerian duct and Wolffian duct in the male and female fetal mouse. J. Morphol 162, 175-210.[Medline]

Fitchett, J. E. and Hay, E. D (1989). Medial edge epithelium transforms to mesenchyme after embryonic palatal shelves fuse. Dev. Biol 131, 455-474.[Medline]

Frisch, S. M. and Francis, H (1994). Disruption of epithelial cell-matrix interaction induces apoptosis. J. Cell Biol 124, 619-626.[Abstract/Free Full Text]

Gosden, R. and Spears, N (1997). Programmed cell death in the reproductive system. Brit. Med. Bull 52, 644-661.[Abstract/Free Full Text]

Hayashi A., Donahoe P. K., Budzik G. P. and Trelstrad, R. L (1982). Periductal and matrix glycosaminoglycans in rat Mullerian duct development and regression. Dev. Biol 92, 16-26.[Medline]

Hsueh, A. J., Billig, H. and Tsafriri, A (1994). Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocrine Rev 15, 707-724.[Medline]

Imbeaud, S, Faure, E., Lamarre, I., Mattei, M. G., di Clemente, N., Tizard, R., Carre-Eusebe, D., Belville, C., Tragethon, L., Tonkin, C. et al (1995). Insensitivity to anti-Mullerian hormone due to a mutation in the human anti-Mullerian hormone receptor. Nat. Genet 11, 382-388.[Medline]

Iwaka, H., Trelstad, R. L., Hutson, J. M., Manganaro, T. F. and Donahoe, P. K (1984). Changing patterns of fibronectin, laminin, type IV collagen, and a basement membrane proteoglycan during rat Mullerian duct regression. Dev. Biol 102, 260-263.[Medline]

Jacobson, M. D., Veil, M. and Raff, M. C (1997). Programmed cell death in animal development. Cell 88, 347-354.[Medline]

Josso, N., Picard, J. Y. and Tran, D (1977). The anti-Mullerian hormone. Recent Prog. Horm. Res 33, 117-160.

Jost, A (1953). Problems of fetal endocrinology. The gonadal and hypophyseal hormones. Recent Prog. Horm. Res 8, 379-418.

Kemler, R (1993). From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9, 315-320.

Lei, H., Furth, E. E., Kalluri, R., Chiou, T., Tilly, K. I., Tilly, J. L. andStrauss III, J. F (1997). A program of cell death and extracellular matrix degradation is activated in the amnion before the onset of labor. J. Clin. Invest 98, 1971-1978.[Medline]

Lei, H., Kalluri, R., Furth, E. E., Baker, A. H. and Strauss III, J. F (1999). Rat amnion type IV collagen composition and metabolism: implications for membrane breakdown. Biol. Reprod 60, 176-182.[Abstract/Free Full Text]

Lyet, L., Louis, F., Forest, M. G., Josso, N., Behringer, R. R. and Vigier, B (1995). Ontogeny of reproductive abnormalities induced by deregulation of anti-Mullerian hormone expression in transgenic mice. Biol. Reprod 52, 444-454.[Abstract]

Meredith, J. E., Fazeli, B. and Schwartz, M. A (1993). The extracellular matrix as cell survival factor. Mol. Biol. Cell 4, 953-961.[Abstract]

Miller, J. R. and Moon, R. T (1996). Signal transduction through-catenin and specification of cell fate during embryogenesis. Genes Dev 10, 2527-2539.[Free Full Text]

Oosterwegel, M., van de Wetering, M., Timmerman, J., Kruisbeek, A., Destree, O., Meijlink, F. and Clevers, H (1993). Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis. Development 118, 439-448.[Abstract]

Papkoff, J., Rubinfeld, B., Schryver, B. and Polakis, B (1996). Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol. Cell. Biol 16, 2128-2134.[Abstract]

Paranko, J., Foidart, J. M. and Pelliniemi, L. J (1986). Developmental changes in interstitial collagens of fetal rat genital ducts. Dev. Biol 113, 364-372.[Medline]

Parr, B. A. and McMahon, A. P (1998). Sexually dimorphic development of mammalian reproductive tract requires Wnt-7a. Nature 395, 707-710.[Medline]

Picon, R (1969). Action du testicule foetal sur le developpement in vitro des canaux de Muller chez le rat. Arch. Anat. Microsc. Morphol. Exp 58, 1-19.[Medline]

Price, J. M., Donahoe, P. K., Ito, Y. and Hendren, W. H (1977). Programmed cell death in the Mullerian duct induced by Mullerian inhibiting substance. Am. J. Anat 149, 353-376.[Medline]

Price, J. M., Donahoe, P. K. and Ito, Y (1979). Involution of the female Mullerian duct of the fetal rat in the organ culture assay for the detection of Mullerian inhibiting substance. Am. J. Anat 156, 265-284.[Medline]

Racine, C., Rey, R., Forest, M. G., Louis, F., Ferre, A., Huhtaniemi, I., Josso, N. and di Clemente, N (1998). Receptors for anti-Mullerian hormone on Leydig cell are responsible for its effects on steroidogenesis and cell differentiation. Proc. Natl Acad. Sci. USA 95, 594-599.[Abstract/Free Full Text]

Resnik, E (1997). -catenin \320 one player, two games. Nature Genet 16, 9-11.[Medline]

Roberts, L. M., Hirokawa, Y., Natchtigal M. W. and Ingraham, H. A (1999). Paracrine-mediated apoptosis in reproductive tract development. Dev. Biol 208, 110-122.[Medline]

Shimizu, H., Julius, M. A., Giarre, M., Zheng, Z., Brown, A. M. C. and Kitajewski, J (1997). Transformation by Wnt family proteins correlates with regulation of-catenin. Cell Growth Differ 8, 1349-1358.[Abstract]

Strange, R., Li, F., Saurer, S., Burkhardt, A. and Friis, R. R (1992). Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development 115, 49-58.[Abstract]

Teixeira, J., He, W. W., Shah, P. C., Morikawa, N., Lee, M. M., Catlin, E. A., Hudson, P. L., Wing, J., MacLaughlin, D. T. and Donahoe, P. K (1996). Developmental expression of a candidate mullerian inhibiting substance type II receptor. Endocrinology 137, 160-165.[Abstract]

Tran, D., Meusy-Dessole, N. and Josso, N (1977). Anti-Mullerian hiormone is a functional marker of foetal Sertoli cells. Nature 269, 411-412.[Medline]

Trelstad, R. L., Hayashi, A., Hayashi, K. and Donahoe, P. K (1982). The epithelial-mesenchymal interface of the rat Mullerian duct: loss of basement membrane integrity and ductal regression. Dev. Biol 92, 27-40.[Medline]

Tsuji, M., Shima, H, Yonemura, C. Y., Brody, J., Donahoe, P. K. and Cunha, G. R (1992). Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat. Endocrinology 131, 1481-1488.[Abstract]

Vainio, S., Heikkil\212, M., Kispert, A., Chin, N. and McMahon, A. P (1999). Female development in mammals is regulated by Wnt-4 signalling. Nature 397, 405-409.[Medline]

van de Klundert, F. A. J. M., Raats, J. M. H. and Bloemendal, H (1993). Intermediate filaments: regulation of gene expression and assembly. Eur. J. Biochem 214, 351-366.[Medline]

Waltzer, L. and Bienz, M (1999). The control of-catenin and TCF duringembryonic development and cancer. Cancer Metast. Rev 18, 231-246.[Medline]

Willert, K. and Nusse, R (1998). -catenin: a key mediator of Wn signaling. Curr. Opin. Genet. Dev 8, 95-102.[Medline]

Wodarz, A. and Nusse, R (1998). Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol 14, 59-88.[Medline]

This article has been cited by other articles:

X. Wu, S. Wan, S. Pujar, M. E. Haskins, D. H. Schlafer, M. M. Lee, and V. N. Meyers-Wallen
A Single Base Pair Mutation Encoding a Premature Stop Codon in the MIS Type II Receptor Is Responsible for Canine Persistent Mullerian Duct Syndrome
J Androl, January 1, 2009; 30(1): 46 - 56.
[Abstract] [Full Text] [PDF]

G.D. Orvis, S.P. Jamin, K.M. Kwan, Y. Mishina, V.M. Kaartinen, S. Huang, A.B. Roberts, L. Umans, D. Huylebroeck, A. Zwijsen, et al.
Functional Redundancy of TGF-beta Family Type I Receptors and Receptor-Smads in Mediating Anti-Mullerian Hormone-Induced Mullerian Duct Regression in the Mouse
Biol Reprod, June 1, 2008; 78(6): 994 - 1001.
[Abstract] [Full Text] [PDF]

P. J. O'Shaughnessy, P. J. Baker, A. Monteiro, S. Cassie, S. Bhattacharya, and P. A. Fowler
Developmental Changes in Human Fetal Testicular Cell Numbers and Messenger Ribonucleic Acid Levels during the Second Trimester
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4792 - 4801.
[Abstract] [Full Text] [PDF]

J. Klattig, R. Sierig, D. Kruspe, B. Besenbeck, and C. Englert
Wilms' Tumor Protein Wt1 Is an Activator of the Anti-Mullerian Hormone Receptor Gene Amhr2
Mol. Cell. Biol., June 15, 2007; 27(12): 4355 - 4364.
[Abstract] [Full Text] [PDF]

T. T. Tran, D. L. Segev, V. Gupta, H. Kawakubo, G. Yeo, P. K. Donahoe, and S. Maheswaran
Mullerian Inhibiting Substance Regulates Androgen-Induced Gene Expression and Growth in Prostate Cancer Cells through a Nuclear Factor-{kappa}B-Dependent Smad-Independent Mechanism
Mol. Endocrinol., October 1, 2006; 20(10): 2382 - 2391.
[Abstract] [Full Text] [PDF]

F. Gao, S. Maiti, N. Alam, Z. Zhang, J. M. Deng, R. R. Behringer, C. Lecureuil, F. Guillou, and V. Huff
The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis
PNAS, August 8, 2006; 103(32): 11987 - 11992.
[Abstract] [Full Text] [PDF]

Y. Zhan, A. Fujino, D. T. MacLaughlin, T. F. Manganaro, P. P. Szotek, N. A. Arango, J. Teixeira, and P. K. Donahoe
Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression
Development, June 15, 2006; 133(12): 2359 - 2369.
[Abstract] [Full Text] [PDF]

T. Piltonen, L. Morin-Papunen, R. Koivunen, A. Perheentupa, A. Ruokonen, and J. S. Tapanainen
Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome
Hum. Reprod., July 1, 2005; 20(7): 1820 - 1826.
[Abstract] [Full Text] [PDF]

S. Y. Park and J. L. Jameson
Minireview: Transcriptional Regulation of Gonadal Development and Differentiation
Endocrinology, March 1, 2005; 146(3): 1035 - 1042.
[Abstract] [Full Text] [PDF]

S. Edlund, S. Y. Lee, S. Grimsby, S. Zhang, P. Aspenstrom, C.-H. Heldin, and M. Landstrom
Interaction between Smad7 and {beta}-Catenin: Importance for Transforming Growth Factor {beta}-Induced Apoptosis
Mol. Cell. Biol., February 15, 2005; 25(4): 1475 - 1488.
[Abstract] [Full Text] [PDF]

J. Aubin, A. Davy, and P. Soriano
In vivo convergence of BMP and MAPK signaling pathways: impact of differential Smad1 phosphorylation on development and homeostasis
Genes & Dev., June 15, 2004; 18(12): 1482 - 1494.
[Abstract] [Full Text] [PDF]

A. Salva, M. P. Hardy, X.-f. Wu, C. M. Sottas, D. T. MacLaughlin, P. K. Donahoe, and M. M. Lee
Mullerian-Inhibiting Substance Inhibits Rat Leydig Cell Regeneration after Ethylene Dimethanesulphonate Ablation
Biol Reprod, March 1, 2004; 70(3): 600 - 607.
[Abstract] [Full Text] [PDF]

A. Kobayashi, W. Shawlot, A. Kania, and R. R. Behringer
Requirement of Lim1 for female reproductive tract development
Development, February 1, 2004; 131(3): 539 - 549.
[Abstract] [Full Text] [PDF]

K. Jeays-Ward, C. Hoyle, J. Brennan, M. Dandonneau, G. Alldus, B. Capel, and A. Swain
Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad
Development, August 15, 2003; 130(16): 3663 - 3670.
[Abstract] [Full Text] [PDF]

A. Hossain and G. F. Saunders
Synergistic Cooperation between the {beta}-Catenin Signaling Pathway and Steroidogenic Factor 1 in the Activation of the Mullerian Inhibiting Substance Type II Receptor
J. Biol. Chem., July 11, 2003; 278(29): 26511 - 26516.
[Abstract] [Full Text] [PDF]

L. M. Roberts, J. A. Visser, and H. A. Ingraham
Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development
Development, March 5, 2003; 129(6): 1487 - 1496.
[Abstract] [Full Text] [PDF]

V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira
Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation
Endocrinology, September 1, 2002; 143(9): 3351 - 3360.
[Abstract] [Full Text] [PDF]

D. L. Segev, Y. Hoshiya, M. Hoshiya, T. T. Tran, J. L. Carey, A. E. Stephen, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo
PNAS, January 1, 2002; (2002) 221599298.
[Abstract] [Full Text] [PDF]

J. Teixeira, S. Maheswaran, and P. K. Donahoe
Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications
Endocr. Rev., October 1, 2001; 22(5): 657 - 674.
[Abstract] [Full Text] [PDF]

L. Messika-Zeitoun, L. Gouedard, C. Belville, M. Dutertre, L. Lins, S. Imbeaud, I. A. Hughes, J.-Y. Picard, N. Josso, and N. di Clemente
Autosomal Recessive Segregation of a Truncating Mutation of Anti-Mullerian Type II Receptor in a Family Affected by the Persistent Mullerian Duct Syndrome Contrasts with Its Dominant Negative Activity in Vitro
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4390 - 4397.
[Abstract] [Full Text] [PDF]

M. Dutertre, L. Gouedard, F. Xavier, W.-Q. Long, N. di Clemente, J.-Y. Picard, and R. Rey
Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Mullerian Hormone in Transgenic Mice
Endocrinology, September 1, 2001; 142(9): 4040 - 4046.
[Abstract] [Full Text] [PDF]

I. A. Hughes
Minireview: Sex Differentiation
Endocrinology, August 1, 2001; 142(8): 3281 - 3287.
[Abstract] [Full Text] [PDF]

T. R. Clarke, Y. Hoshiya, S. E. Yi, X. Liu, K. M. Lyons, and P. K. Donahoe
Mullerian Inhibiting Substance Signaling Uses a Bone Morphogenetic Protein (BMP)-Like Pathway Mediated by ALK2 and Induces Smad6 Expression
Mol. Endocrinol., June 1, 2001; 15(6): 946 - 959.
[Abstract] [Full Text] [PDF]

S. Nef and L. F. Parada
Hormones in male sexual development
Genes & Dev., December 15, 2000; 14(24): 3075 - 3086.
[Full Text]

D. L. Segev, Y. Hoshiya, M. Hoshiya, T. T. Tran, J. L. Carey, A. E. Stephen, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran
Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo
PNAS, January 8, 2002; 99(1): 239 - 244.
[Abstract] [Full Text] [PDF]

This Article

Summary

Full Text (PDF)

Alert me when this article is cited

Alert me if a correction is posted

Services

Email this article to a friend

Similar articles in this journal

Similar articles in PubMed

Alert me to new issues of the journal

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via Google Scholar

Google Scholar

Articles by Allard, S.

Articles by Xavier, F.

Search for Related Content

PubMed

PubMed Citation

Articles by Allard, S.

Articles by Xavier, F.

				G.D. Orvis, S.P. Jamin, K.M. Kwan, Y. Mishina, V.M. Kaartinen, S. Huang, A.B. Roberts, L. Umans, D. Huylebroeck, A. Zwijsen, et al. Functional Redundancy of TGF-beta Family Type I Receptors and Receptor-Smads in Mediating Anti-Mullerian Hormone-Induced Mullerian Duct Regression in the Mouse Biol Reprod, June 1, 2008; 78(6): 994 - 1001. [Abstract] [Full Text] [PDF]

				P. J. O'Shaughnessy, P. J. Baker, A. Monteiro, S. Cassie, S. Bhattacharya, and P. A. Fowler Developmental Changes in Human Fetal Testicular Cell Numbers and Messenger Ribonucleic Acid Levels during the Second Trimester J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4792 - 4801. [Abstract] [Full Text] [PDF]

				J. Klattig, R. Sierig, D. Kruspe, B. Besenbeck, and C. Englert Wilms' Tumor Protein Wt1 Is an Activator of the Anti-Mullerian Hormone Receptor Gene Amhr2 Mol. Cell. Biol., June 15, 2007; 27(12): 4355 - 4364. [Abstract] [Full Text] [PDF]

				T. T. Tran, D. L. Segev, V. Gupta, H. Kawakubo, G. Yeo, P. K. Donahoe, and S. Maheswaran Mullerian Inhibiting Substance Regulates Androgen-Induced Gene Expression and Growth in Prostate Cancer Cells through a Nuclear Factor-{kappa}B-Dependent Smad-Independent Mechanism Mol. Endocrinol., October 1, 2006; 20(10): 2382 - 2391. [Abstract] [Full Text] [PDF]

				F. Gao, S. Maiti, N. Alam, Z. Zhang, J. M. Deng, R. R. Behringer, C. Lecureuil, F. Guillou, and V. Huff The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis PNAS, August 8, 2006; 103(32): 11987 - 11992. [Abstract] [Full Text] [PDF]

				Y. Zhan, A. Fujino, D. T. MacLaughlin, T. F. Manganaro, P. P. Szotek, N. A. Arango, J. Teixeira, and P. K. Donahoe Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression Development, June 15, 2006; 133(12): 2359 - 2369. [Abstract] [Full Text] [PDF]

				T. Piltonen, L. Morin-Papunen, R. Koivunen, A. Perheentupa, A. Ruokonen, and J. S. Tapanainen Serum anti-Mullerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome Hum. Reprod., July 1, 2005; 20(7): 1820 - 1826. [Abstract] [Full Text] [PDF]

				S. Y. Park and J. L. Jameson Minireview: Transcriptional Regulation of Gonadal Development and Differentiation Endocrinology, March 1, 2005; 146(3): 1035 - 1042. [Abstract] [Full Text] [PDF]

				S. Edlund, S. Y. Lee, S. Grimsby, S. Zhang, P. Aspenstrom, C.-H. Heldin, and M. Landstrom Interaction between Smad7 and {beta}-Catenin: Importance for Transforming Growth Factor {beta}-Induced Apoptosis Mol. Cell. Biol., February 15, 2005; 25(4): 1475 - 1488. [Abstract] [Full Text] [PDF]

				J. Aubin, A. Davy, and P. Soriano In vivo convergence of BMP and MAPK signaling pathways: impact of differential Smad1 phosphorylation on development and homeostasis Genes & Dev., June 15, 2004; 18(12): 1482 - 1494. [Abstract] [Full Text] [PDF]

				A. Salva, M. P. Hardy, X.-f. Wu, C. M. Sottas, D. T. MacLaughlin, P. K. Donahoe, and M. M. Lee Mullerian-Inhibiting Substance Inhibits Rat Leydig Cell Regeneration after Ethylene Dimethanesulphonate Ablation Biol Reprod, March 1, 2004; 70(3): 600 - 607. [Abstract] [Full Text] [PDF]

				A. Kobayashi, W. Shawlot, A. Kania, and R. R. Behringer Requirement of Lim1 for female reproductive tract development Development, February 1, 2004; 131(3): 539 - 549. [Abstract] [Full Text] [PDF]

				K. Jeays-Ward, C. Hoyle, J. Brennan, M. Dandonneau, G. Alldus, B. Capel, and A. Swain Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad Development, August 15, 2003; 130(16): 3663 - 3670. [Abstract] [Full Text] [PDF]

				A. Hossain and G. F. Saunders Synergistic Cooperation between the {beta}-Catenin Signaling Pathway and Steroidogenic Factor 1 in the Activation of the Mullerian Inhibiting Substance Type II Receptor J. Biol. Chem., July 11, 2003; 278(29): 26511 - 26516. [Abstract] [Full Text] [PDF]

				L. M. Roberts, J. A. Visser, and H. A. Ingraham Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development Development, March 5, 2003; 129(6): 1487 - 1496. [Abstract] [Full Text] [PDF]

				V. M. Laurich, A. M. Trbovich, F. H. O'Neill, C. P. Houk, P. M. Sluss, A. H. Payne, P. K. Donahoe, and J. Teixeira Mullerian Inhibiting Substance Blocks the Protein Kinase A-Induced Expression of Cytochrome P450 17{alpha}-Hydroxylase/C17-20 Lyase mRNA in a Mouse Leydig Cell Line Independent of cAMP Responsive Element Binding Protein Phosphorylation Endocrinology, September 1, 2002; 143(9): 3351 - 3360. [Abstract] [Full Text] [PDF]

				D. L. Segev, Y. Hoshiya, M. Hoshiya, T. T. Tran, J. L. Carey, A. E. Stephen, D. T. MacLaughlin, P. K. Donahoe, and S. Maheswaran Mullerian-inhibiting substance regulates NF-kappa B signaling in the prostate in vitro and in vivo PNAS, January 1, 2002; (2002) 221599298. [Abstract] [Full Text] [PDF]

				J. Teixeira, S. Maheswaran, and P. K. Donahoe Mullerian Inhibiting Substance: An Instructive Developmental Hormone with Diagnostic and Possible Therapeutic Applications Endocr. Rev., October 1, 2001; 22(5): 657 - 674. [Abstract] [Full Text] [PDF]

				L. Messika-Zeitoun, L. Gouedard, C. Belville, M. Dutertre, L. Lins, S. Imbeaud, I. A. Hughes, J.-Y. Picard, N. Josso, and N. di Clemente Autosomal Recessive Segregation of a Truncating Mutation of Anti-Mullerian Type II Receptor in a Family Affected by the Persistent Mullerian Duct Syndrome Contrasts with Its Dominant Negative Activity in Vitro J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4390 - 4397. [Abstract] [Full Text] [PDF]

				M. Dutertre, L. Gouedard, F. Xavier, W.-Q. Long, N. di Clemente, J.-Y. Picard, and R. Rey Ovarian Granulosa Cell Tumors Express a Functional Membrane Receptor for Anti-Mullerian Hormone in Transgenic Mice Endocrinology, September 1, 2001; 142(9): 4040 - 4046. [Abstract] [Full Text] [PDF]

				I. A. Hughes Minireview: Sex Differentiation Endocrinology, August 1, 2001; 142(8): 3281 - 3287. [Abstract] [Full Text] [PDF]

				T. R. Clarke, Y. Hoshiya, S. E. Yi, X. Liu, K. M. Lyons, and P. K. Donahoe Mullerian Inhibiting Substance Signaling Uses a Bone Morphogenetic Protein (BMP)-Like Pathway Mediated by ALK2 and Induces Smad6 Expression Mol. Endocrinol., June 1, 2001; 15(6): 946 - 959. [Abstract] [Full Text] [PDF]

				S. Nef and L. F. Parada Hormones in male sexual development Genes & Dev., December 15, 2000; 14(24): 3075 - 3086. [Full Text]